Chronic Obstructive Pulmonary Disease Treatment Devices Market

DelveInsight’s ‘Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Chronic Obstructive Pulmonary Disease Treatment Devices and the historical and forecasted Chronic Obstructive Pulmonary Disease Treatment Devices market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.


The Chronic Obstructive Pulmonary Disease Treatment Devices market report provides an overview of Chronic Obstructive Pulmonary Disease Treatment Devices, applications of Chronic Obstructive Pulmonary Disease Treatment Devices as well as its PEST Analysis. Additionally, the report provides insight on the Chronic Obstructive Pulmonary Disease Treatment Devices market share of the individual Chronic Obstructive Pulmonary Disease Treatment Devices, current and forecasted Chronic Obstructive Pulmonary Disease Treatment Devices market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Chronic Obstructive Pulmonary Disease Overview

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. Emphysema and chronic bronchitis are the two most common conditions that contribute to COPD. These two conditions usually occur together and can vary in severity among individuals with COPD.

 

Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Spain, Italy, and the United Kingdom)
  • Japan

List of Companies

  • GlaxoSmithKline plc.
  • Novartis AG
  • Merck & Co., Inc.
  • Koninklijke Philips N.V.
  • AstraZeneca
  • 3M
  • GF HEALTH PRODUCTS, INC
  • Sunovion Pharmaceuticals Inc.
  • Smiths Medical
  • Baxter

Chronic Obstructive Pulmonary Disease Treatment Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Chronic Obstructive Pulmonary Disease Treatment Devices, to help understand the competition in the market. It gives a comparative understanding of the products based on its type.

Chronic Obstructive Pulmonary Disease Treatment Devices: Market Segmentation

By Device

  • Inhalers
  • Metered dose inhalers (MDIs)
  • Dry powder inhalers (DPIs)
  • Soft mist inhalers (SMIs)
  • Nebulizers
  • Jet nebulizers
  • Mesh nebulizers
  • Ultrasonic nebulizers


By End-User

  • Hospitals & Clinics
  • Home Care Settings

Chronic Obstructive Pulmonary Disease Treatment Devices: Market Dynamics

Market Drivers

  • Rise in prevalence of COPD
  • Growing adoption of non-invasive treatment for COPD
  • Technological advancement


Market Barriers

  • Lack of skilled professionals
  • Dearth of knowledge among patients

Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis

This segment illustrates the market of Chronic Obstructive Pulmonary Disease Treatment Devices across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Chronic Obstructive Pulmonary Disease Treatment Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Chronic Obstructive Pulmonary Disease Treatment Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Chronic Obstructive Pulmonary Disease Treatment Devices, explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Chronic Obstructive Pulmonary Disease Treatment Devices is provided, which will have an impact on the future market of Chronic Obstructive Pulmonary Disease Treatment Devices.
  • A detailed review of Chronic Obstructive Pulmonary Disease Treatment Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Chronic Obstructive Pulmonary Disease Treatment Devices market.

Report Highlights

  • The report covers descriptive overview of the Chronic Obstructive Pulmonary Disease Treatment Devices, explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Chronic Obstructive Pulmonary Disease Treatment Devices market.
  • The report also reviews the detailed historical and forecasted Chronic Obstructive Pulmonary Disease Treatment Devices market, including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Chronic Obstructive Pulmonary Disease Treatment Devices market.

Chronic Obstructive Pulmonary Disease Treatment Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Chronic Obstructive Pulmonary Disease Treatment Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Chronic Obstructive Pulmonary Disease Treatment Devices market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Chronic Obstructive Pulmonary Disease Treatment Devices total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across the 7MM and which country will have the largest Chronic Obstructive Pulmonary Disease Treatment Devices market size during the forecast period (2018–2026)?
  • At what CAGR, the Chronic Obstructive Pulmonary Disease Treatment Devices market is expected to grow in the 7MM during the forecast period (2018–2026)?
  • What will be the Chronic Obstructive Pulmonary Disease Treatment Devices market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Chronic Obstructive Pulmonary Disease Treatment Devices market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Chronic Obstructive Pulmonary Disease Treatment Devices?
  • What is the Chronic Obstructive Pulmonary Disease Treatment Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Chronic Obstructive Pulmonary Disease Treatment Devices?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Chronic Obstructive Pulmonary Disease Treatment Devices?
  • What are the key designations that have been granted for the current Chronic Obstructive Pulmonary Disease Treatment Devices?
  • What are the 7MM countries historical and forecasted market of Chronic Obstructive Pulmonary Disease Treatment Devices?

Frequently Asked Questions

What is Chronic Obstructive Pulmonary Disease Treatment Devices?

Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing.


How is Chronic Obstructive Pulmonary Disease Treatment Devices Market Segmented?

The Chronic Obstructive Pulmonary Disease Treatment Devices is segmented on the basis by Device, and by End user.


Who are the leading companies in Chronic Obstructive Pulmonary Disease Treatment Devices Market Landscape?

The leading companies that are working in the Chronic Obstructive Pulmonary Disease Treatment Devices Market are GlaxoSmithKline plc. Novartis AG, Merck & Co., Inc., Koninklijke Philips N.V., AstraZeneca, 3M, GF HEALTH PRODUCTS, INC, Sunovion Pharmaceuticals Inc., Smiths Medical, Baxter, and many others.


What are the Chronic Obstructive Pulmonary Disease Treatment Devices Market Drivers?

The market driver is rise in prevalence of COPD, growing adoption of non-invasive treatment for COPD, and technological advancement.


What are the Chronic Obstructive Pulmonary Disease Treatment Devices Market Barriers?

The market barrier is lack of skilled professionals and dearth of knowledge among patients.


What are the key strengths of Chronic Obstructive Pulmonary Disease Treatment Devices Market Report?

Key strengths of Chronic Obstructive Pulmonary Disease Treatment Devices Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of COVID-19 on Chronic Obstructive Pulmonary Disease Treatment Devices Market?

The Chronic Obstructive Pulmonary Disease Treatment Devices Market had observed a positive shift in market revenues due to the COVID 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1. Key Insights

2. Executive Summary of Chronic Obstructive Pulmonary Disease Treatment Devices

3. Chronic Obstructive Pulmonary Disease Treatment Devices: Background and Overview

3.1. Introduction

3.2. Types of Chronic Obstructive Pulmonary Disease Treatment Devices

3.3. Advantages of Chronic Obstructive Pulmonary Disease Treatment Devices

3.4. Disadvantages of Chronic Obstructive Pulmonary Disease Treatment Devices

4. Chronic Obstructive Pulmonary Disease Treatment Devices: Regulatory Scenario

5. Chronic Obstructive Pulmonary Disease Treatment Devices: Reimbursement Scenario

6. Company Profiles

6.1. Smiths Medical

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. Koninklijke Philips N.V.

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

More companies in the final report…

7. Chronic Obstructive Pulmonary Disease Treatment Devices: Competitive Analysis

8. KOL Views

9. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in 7MM

9.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in 7MM by Device (2018–2026)

9.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in 7MM by End user (2018–2026)

10. Country-Wise Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in 7MM (2018–2026)

10.1. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in the United States

10.1.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the United States by Device (2018–2026)

10.1.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the United States by End user (2018–2026)

10.2. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in Germany

10.2.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Germany by Device (2018–2026)

10.2.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Germany by End user (2018–2026)

10.3. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in France

10.3.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in France by Device (2018–2026)

10.3.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in France by End user (2018–2026)

10.4. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in Spain

10.4.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Spain by Device (2018–2026)

10.4.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Spain by End user (2018–2026)

10.5. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in Italy

10.5.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Italy by Device (2018–2026)

10.5.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Italy by End user (2018–2026)

10.6. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in the UK

10.6.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the UK by Device (2018–2026)

10.6.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the UK by End user (2018–2026)

10.7. Market size of Chronic Obstructive Pulmonary Disease Treatment Devices in Japan

10.7.1. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Japan by Device (2018–2026)

10.7.2. Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Japan by End user (2018–2026)

11. Market Dynamic

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the 7MM (2018–2026)

Table 3: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the 7MM by Device (2018–2026)

Table 4: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the 7MM by End user (2018–2026)

Table 5: Chronic Obstructive Pulmonary Disease Treatment Devices: United States Market Analysis (2018–2026)

Table 6: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the US by Device (2018-2026)

Table 7: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the US by End user (2018-2026)

Table 8: Chronic Obstructive Pulmonary Disease Treatment Devices: Germany Market Analysis (2018–2026)

Table 9: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Germany by Device (2018-2026)

Table 10: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Germany by End user (2018-2026)

Table 11: Chronic Obstructive Pulmonary Disease Treatment Devices: France Market Analysis (2018–2026)

Table 12: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in France by Device (2018-2026)

Table 13: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in France by End user (2018-2026)

Table 14: Chronic Obstructive Pulmonary Disease Treatment Devices: Spain Market Analysis (2018–2026)

Table 15: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Spain by Device (2018-2026)

Table 16: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Spain by End user (2018-2026)

Table 17: Chronic Obstructive Pulmonary Disease Treatment Devices: Italy Market Analysis (2018–2026)

Table 18: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Italy by Device (2018-2026)

Table 19: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Italy by End user (2018-2026)

Table 20: Chronic Obstructive Pulmonary Disease Treatment Devices: United Kingdom Market Analysis (2018–2026)

Table 21: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the UK by Device (2018-2026)

Table 22: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the UK by End user (2018-2026)

Table 23: Chronic Obstructive Pulmonary Disease Treatment Devices: Japan Market Analysis (2018–2026)

Table 24: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Japan by Device (2018-2026)

Table 25: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Japan by End user (2018-2026)

List of Figures

Figure 1: Product description of Chronic Obstructive Pulmonary Disease Treatment Devices

Figure 2: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the 7MM (2018–2026)

Figure 3: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the 7MM by Device (2018–2026)

Figure 4: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the 7MM by End user (2018–2026)

Figure 5: Chronic Obstructive Pulmonary Disease Treatment Devices: United States Market Analysis (2018–2026)

Figure 6: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the US by Device (2018-2026)

Figure 7: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the US by End user (2018-2026)

Figure 8: Chronic Obstructive Pulmonary Disease Treatment Devices: Germany Market Analysis (2018–2026)

Figure 9: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Germany by Device (2018-2026)

Figure 10: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Germany by End user (2018-2026)

Figure 11: Chronic Obstructive Pulmonary Disease Treatment Devices: France Market Analysis (2018–2026)

Figure 12: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in France by Device (2018-2026)

Figure 13: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in France by End user (2018-2026)

Figure 14: Chronic Obstructive Pulmonary Disease Treatment Devices: Spain Market Analysis (2018–2026)

Figure 15: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Spain by Device (2018-2026)

Figure 16: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Spain by End user (2018-2026)

Figure 17: Chronic Obstructive Pulmonary Disease Treatment Devices: Italy Market Analysis (2018–2026)

Figure 18: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Italy by Device (2018-2026)

Figure 19: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Italy by End user (2018-2026)

Figure 20: Chronic Obstructive Pulmonary Disease Treatment Devices: United Kingdom Market Analysis (2018–2026)

Figure 21: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the UK by Device (2018-2026)

Figure 22: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in the UK by End user (2018-2026)

Figure 23: Chronic Obstructive Pulmonary Disease Treatment Devices: Japan Market Analysis (2018–2026)

Figure 24: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Japan by Device (2018-2026)

Figure 25: Chronic Obstructive Pulmonary Disease Treatment Devices: Market Analysis in Japan by End user (2018-2026)

Figure 26: Market Drivers

Figure 27: Market Barriers

GlaxoSmithKline plc.

Novartis AG

Merck & Co., Inc.

Koninklijke Philips N.V.

AstraZeneca

3M

GF HEALTH PRODUCTS, INC

Sunovion Pharmaceuticals Inc.

Smiths Medical

Baxter

  • Tags:
  • Chronic Obstructive Pulmonary Disea...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...
  • Chronic Obstructive Pulmonary Dise...

Forward to Friend

Need A Quote